Newsletter SignupSearch

Learn about biomarkers, their utility in diagnosing and predicting brain disorders, and their potential to revolutionize treatment for these conditions.

Speakers:

Chantelle Farland-Beckham, PhD
Chantelle Ferland-Beckham, PhD
Director of Policy & Advocacy, Cohen Veterans Bioscience

Heather Lasseter, PhD
Heather Lasseter, PhD
Associate Director, Scientific Programs, Cohen Veterans Bioscience

References:

  1. Atkinson, Arthur & Colburn, Wayne & Degruttola, Victor & Demets, David & Downing, Gregory & Hoth, Daniel & Oates, John & Peck, Carl & Schooley, Robert & Spilker, Bert & Woodcock, Janet & Zeger, Scott. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*. Clin Pharmacol Ther. 69. 89-95.

Magali Haas, MD, PhD
CEO & President, Cohen Veterans Bioscience

Dr. Haas is founder of Cohen Veterans Bioscience (CVB), a global organization that leads pioneering efforts in PTSD and TBI research, including clinical trials, biotechnology, genetics, and biomarker discovery. She has more than 15 years of pharmaceutical leadership experience in neuroscience clinical development, translational medicine, and diagnostics, primarily at J&J. Dr. Haas has spearheaded the Brain Trauma Blueprint initiative to establish a national roadmap for PTSD & TBI precision therapeutics research.

Jamshid Ghajar, MD, PhD, FACS
President Emeritus, Brain Trauma Foundation

Dr. Ghajar is a board-certified neurosurgeon. In 2014, he joined the neurosurgery faculty at Stanford, where he is a clinical professor of neurosurgery and the Moghadam Family Director of the Stanford Brain Performance Center, Stanford University School of Medicine. He founded the Brain Trauma Foundation to develop and implement best practice guidelines for TBI, with the goal of improving patients’ lives.

Speakers:

Jennifer Sumner, PhD
Jennifer A. Sumner, PhD
Assistant Professor, Department of Psychology, UCLA

Heather Lasseter, PhD
Heather Lasseter, PhD
Associate Director, Scientific Programs, Cohen Veterans Bioscience

Moderator:

Andreas Jeromin, PhD

Andreas Jeromin, PhD
Chief Scientific Officer, Cohen Veterans Bioscience